MiR-33b expression was determined in four human BC cell lines, including MDA-MB-468, MCF-7, BT474, and SKBR3 (HER2+), with the non-tumorigenic epithelial cell lines MCF12A and MCF-10A as controls. This evidence concerns the gene ERBB2 and breast cancer.